NCT01701258View on ClinicalTrials.gov

An Investigation of Early Life Stress and Depression

PHASE1CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Major Depressive Disorder (MDD)History of Childhood Sexual Abuse (CSA)
Interventions
DRUG

Amisulpride

single low-dose pharmacological challenge, 50 mg amisulpride during the fMRI session only

DRUG

Placebo

single-dose placebo capsule during the fMRI session only

Trial Locations (2)

02478

McLean Hospital, Belmont

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Massachusetts General Hospital

OTHER

lead

Mclean Hospital

OTHER

NCT01701258 - An Investigation of Early Life Stress and Depression | Biotech Hunter | Biotech Hunter